Oklahoma

NACDS is soliciting members’ comments this week on the implementation of the Bureau of Narcotics and Dangerous Drugs Control’s recent announcement regarding changes to the prescription drug monitoring program (PDMP) reporting requirements. As a result of the enactment of Oklahoma SB 848, prescribers are required to document any opioid prescription as being acute or chronic on the face of the prescription. As a result, the PDMP is looking to utilize this data by requiring pharmacies to report any opioid as being used for the treatment of acute or chronic pain. Along with this requirement, the PDMP is also requiring pharmacies to report a value of “99-Other” for any non-opioid controlled substance prescription.

NACDS’ analysis of this change is that most pharmacies will need to implement a block in their prescription fulfillment systems to ensure treatment type codes are being entered and reported accordingly for all opioid prescriptions in accordance with SB 848. This is creating a concern in that requiring a value of “99-Other” for all non-opioid controlled substances will create workflow issues in pharmacies which will cause a negative impact for patients.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Michael Angeloni2019-08-08T09:29:33-04:00August 8, 2019|Oklahoma|

Oklahoma

The Board of Pharmacy requires an annual inventory of all controlled dangerous substances that must be taken between May 1 and July 1, and a copy of this inventory should be included with the pharmacy renewal application and kept on file at the pharmacy for Board inspections.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Michael Angeloni2019-06-13T09:53:55-04:00June 13, 2019|Oklahoma|

Oklahoma

Gov. Kevin Stitt (R) signed into law SB 848, limiting Schedule II controlled substance prescriptions for acute pain to a seven-day supply.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Michael Angeloni2019-06-06T15:10:55-04:00June 6, 2019|Oklahoma|

Oklahoma

Marty Hendrick, Pharm. D, D.Ph., has been named as the new executive director of the Board of Pharmacy effective May 28. Previously, Dr. Hendrick served as a compliance officer for the Board and worked in both independent and chain pharmacies.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Michael Angeloni2019-05-16T16:03:48-04:00May 16, 2019|Oklahoma|

Oklahoma

SB 856, legislation by pharmacist Sen. Rob Standridge (R) that would have set the pharmacy technician to pharmacist ratio in statute at 2:1 which passed the Senate last month, died in the House Business and Commerce Committee.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Karen White2019-05-03T08:48:56-04:00May 2, 2019|Oklahoma|

Oklahoma

Last week, the Board of Pharmacy approved regulations NACDS supported that if approved by the Legislature, will increase the pharmacy technician to pharmacist ratio from 2:1 to 5:1.

Also in Oklahoma… NACDS is closely monitoring SB 856, legislation pending in the House Health Committee that pharmacies oppose filed by pharmacist Sen. Rob Standridge (R) that would limit the technician to pharmacist ratio to 2:1.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Karen White2019-04-05T11:10:41-04:00April 4, 2019|Oklahoma|

Oklahoma

Effective January 7, 2019, the Oklahoma Health Care Authority implemented Phase 1 of a daily Morphine Milligram Equivalent (MME) limit for SoonerCare (Medicaid) pharmacy claims. It covers both short-acting and long-acting opioid formulations. Opioid MME daily totals exceeding 240 will require prior authorization (PA) with patient-specific, clinically significant reasoning why the member requires more than 240 MME per day.* This limit will gradually decrease over a six-month period, allowing providers to develop and implement tapering plans for appropriate patients. The end goal is a target of 100 MME or less.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Michael Angeloni2019-02-05T13:57:39-05:00January 18, 2019|Oklahoma|

Oklahoma

Earlier this month, the Health Care Authority approved an across-the-board Sooner-Care (Medicaid) provider reimbursement rate increase effective Monday, October 1. The three percent increase, or 32-cent increase in the dispensing fee to $10.87 for pharmacies, is effective Monday, October 1.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Karen White2018-10-01T13:30:25-04:00September 28, 2018|Oklahoma|

Oklahoma

The Board of Pharmacy announced that former Board Member Dorothy Gourley, D.Ph. will serve as interim executive director while the Board conducts a search for a new executive director.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Karen White2018-08-17T09:31:43-04:00August 16, 2018|Oklahoma|